
[Federal Register Volume 82, Number 130 (Monday, July 10, 2017)]
[Notices]
[Page 31783]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14365]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-1486]


Authorizations of Emergency Use of In Vitro Diagnostic Devices 
for Detection of Zika Virus; Availability; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration is correcting a notice 
entitled ``Authorizations of Emergency Use of In Vitro Diagnostic 
Devices for Detection of Zika Virus; Availability'' that appeared in 
the Federal Register of June 30, 2017 (82 FR 29886). The document 
announced the issuance of two Emergency Use Authorizations for in vitro 
diagnostic devices for detection of the Zika virus in response to the 
Zika virus outbreak in the Americas. The document was published with 
the incorrect docket number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy and 
Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.

SUPPLEMENTARY INFORMATION: In the Federal Register of Friday, June 30, 
2017, in FR Doc. 2017-13720, on page 29866, the following correction is 
made:
    1. On page 29866, in the first column, in the headings section at 
the beginning of the document, the docket number is corrected to read 
``FDA-2016-N-1486''.

    Dated: June 30, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-14365 Filed 7-7-17; 8:45 am]
 BILLING CODE 4164-01-P


